DNA Chip Research Inc. (TYO:2397)
Japan
· Delayed Price · Currency is JPY 1,090.00
0.00 (0.00%)
May 2, 2025, 3:30 PM JST
DNA Chip Research Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
| Revenue | 962 | 490 | 327 | 427 | 324 | 361 | Upgrade
|
| Revenue Growth (YoY) | 123.20% | 49.85% | -23.42% | 31.79% | -10.25% | 0.28% | Upgrade
|
| Cost of Revenue | 510 | 424 | 363 | 339 | 258 | 272 | Upgrade
|
| Gross Profit | 452 | 66 | -36 | 88 | 66 | 89 | Upgrade
|
| Selling, General & Admin | 420 | 255 | 262 | 191 | 173 | 162 | Upgrade
|
| Research & Development | 69 | 69 | 65 | 64 | 65 | 51 | Upgrade
|
| Operating Expenses | 489 | 324 | 327 | 255 | 238 | 213 | Upgrade
|
| Operating Income | -37 | -258 | -363 | -167 | -172 | -124 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | - | -1 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 11 | 11 | -2 | 28 | -3 | -4 | Upgrade
|
| EBT Excluding Unusual Items | -26 | -247 | -365 | -140 | -175 | -128 | Upgrade
|
| Asset Writedown | -1 | - | -4 | -10 | - | - | Upgrade
|
| Other Unusual Items | -7 | - | 8 | 16 | 3 | - | Upgrade
|
| Pretax Income | -34 | -247 | -361 | -134 | -172 | -128 | Upgrade
|
| Income Tax Expense | 1 | 1 | 1 | - | - | - | Upgrade
|
| Net Income | -35 | -248 | -362 | -134 | -172 | -128 | Upgrade
|
| Net Income to Common | -35 | -248 | -362 | -134 | -172 | -128 | Upgrade
|
| Shares Outstanding (Basic) | 7 | 6 | 6 | 6 | 6 | 5 | Upgrade
|
| Shares Outstanding (Diluted) | 7 | 6 | 6 | 6 | 6 | 5 | Upgrade
|
| Shares Change (YoY) | 6.17% | 8.33% | 1.33% | 1.99% | 11.53% | 13.66% | Upgrade
|
| EPS (Basic) | -5.25 | -39.02 | -61.70 | -23.15 | -30.30 | -25.15 | Upgrade
|
| EPS (Diluted) | -5.25 | -39.02 | -61.70 | -23.15 | -30.30 | -25.15 | Upgrade
|
| Free Cash Flow | - | -147 | -430 | -79 | -85 | -286 | Upgrade
|
| Free Cash Flow Per Share | - | -23.13 | -73.29 | -13.64 | -14.97 | -56.19 | Upgrade
|
| Gross Margin | 46.98% | 13.47% | -11.01% | 20.61% | 20.37% | 24.65% | Upgrade
|
| Operating Margin | -3.85% | -52.65% | -111.01% | -39.11% | -53.09% | -34.35% | Upgrade
|
| Profit Margin | -3.64% | -50.61% | -110.70% | -31.38% | -53.09% | -35.46% | Upgrade
|
| Free Cash Flow Margin | - | -30.00% | -131.50% | -18.50% | -26.24% | -79.22% | Upgrade
|
| EBITDA | 22 | -217 | -346 | -151 | -151 | -106 | Upgrade
|
| EBITDA Margin | 2.29% | -44.29% | -105.81% | -35.36% | -46.61% | -29.36% | Upgrade
|
| D&A For EBITDA | 59 | 41 | 17 | 16 | 21 | 18 | Upgrade
|
| EBIT | -37 | -258 | -363 | -167 | -172 | -124 | Upgrade
|
| EBIT Margin | -3.85% | -52.65% | -111.01% | -39.11% | -53.09% | -34.35% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.